スマトリプタンオートインジェクターのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Sumatriptan Autoinjector Market Insights and Forecast to 2028

• レポートコード：QY2203B03663 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のスマトリプタンオートインジェクターの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスマトリプタンオートインジェクターの世界市場のxxx％を占める「4mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のスマトリプタンオートインジェクターの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのスマトリプタンオートインジェクター市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのスマトリプタンオートインジェクター市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 スマトリプタンオートインジェクターのグローバル主要メーカーには、GlaxoSmithKline、Pfizer、Teva、Sun Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 スマトリプタンオートインジェクター市場は、種類と用途によって区分されます。世界のスマトリプタンオートインジェクター市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 4mg、6mg、その他 【用途別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - スマトリプタンオートインジェクター製品概要 - 種類別市場（4mg、6mg、その他） - 用途別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のスマトリプタンオートインジェクター販売量予測2017-2028 - 世界のスマトリプタンオートインジェクター売上予測2017-2028 - スマトリプタンオートインジェクターの地域別販売量 - スマトリプタンオートインジェクターの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別スマトリプタンオートインジェクター販売量 - 主要メーカー別スマトリプタンオートインジェクター売上 - 主要メーカー別スマトリプタンオートインジェクター価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（4mg、6mg、その他） - スマトリプタンオートインジェクターの種類別販売量 - スマトリプタンオートインジェクターの種類別売上 - スマトリプタンオートインジェクターの種類別価格 ・用途別市場規模（病院、診療所、その他） - スマトリプタンオートインジェクターの用途別販売量 - スマトリプタンオートインジェクターの用途別売上 - スマトリプタンオートインジェクターの用途別価格 ・北米市場 - 北米のスマトリプタンオートインジェクター市場規模（種類別、用途別） - 主要国別のスマトリプタンオートインジェクター市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのスマトリプタンオートインジェクター市場規模（種類別、用途別） - 主要国別のスマトリプタンオートインジェクター市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のスマトリプタンオートインジェクター市場規模（種類別、用途別） - 主要国別のスマトリプタンオートインジェクター市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のスマトリプタンオートインジェクター市場規模（種類別、用途別） - 主要国別のスマトリプタンオートインジェクター市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのスマトリプタンオートインジェクター市場規模（種類別、用途別） - 主要国別のスマトリプタンオートインジェクター市場規模（トルコ、サウジアラビア） ・企業情報 GlaxoSmithKline、Pfizer、Teva、Sun Pharma ・産業チェーン及び販売チャネル分析 - スマトリプタンオートインジェクターの産業チェーン分析 - スマトリプタンオートインジェクターの原材料 - スマトリプタンオートインジェクターの生産プロセス - スマトリプタンオートインジェクターの販売及びマーケティング - スマトリプタンオートインジェクターの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - スマトリプタンオートインジェクターの産業動向 - スマトリプタンオートインジェクターのマーケットドライバー - スマトリプタンオートインジェクターの課題 - スマトリプタンオートインジェクターの阻害要因 ・主な調査結果

Sumatriptan has been in use for the treatment of acute migraine headache for almost 2 decades. Initially, sumatriptan was available only in an injectable formulation; using an “autoinjector” specifically designed for the drug, sumatriptan can be delivered subcutaneously (just below the skin surface) via a small needle.
Market Analysis and Insights: Global Sumatriptan Autoinjector Market
Due to the COVID-19 pandemic, the global Sumatriptan Autoinjector market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 4mg accounting for % of the Sumatriptan Autoinjector global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Sumatriptan Autoinjector market size is valued at US$ million in 2021, while the US and Europe Sumatriptan Autoinjector are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Sumatriptan Autoinjector landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Sumatriptan Autoinjector include GlaxoSmithKline, Pfizer, Teva and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Sumatriptan Autoinjector Scope and Segment
Sumatriptan Autoinjector market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Sumatriptan Autoinjector market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
4mg
6mg
Others
Segment by Application
Hospitals
Clinics
Others
By Company
GlaxoSmithKline
Pfizer
Teva
Sun Pharma
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Sumatriptan Autoinjector Product Introduction
1.2 Market by Type
1.2.1 Global Sumatriptan Autoinjector Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 4mg
1.2.3 6mg
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sumatriptan Autoinjector Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sumatriptan Autoinjector Sales Estimates and Forecasts 2017-2028
2.2 Global Sumatriptan Autoinjector Revenue Estimates and Forecasts 2017-2028
2.3 Global Sumatriptan Autoinjector Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sumatriptan Autoinjector Sales by Region
2.4.1 Global Sumatriptan Autoinjector Sales by Region (2017-2022)
2.4.2 Global Sales Sumatriptan Autoinjector by Region (2023-2028)
2.5 Global Sumatriptan Autoinjector Revenue by Region
2.5.1 Global Sumatriptan Autoinjector Revenue by Region (2017-2022)
2.5.2 Global Sumatriptan Autoinjector Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sumatriptan Autoinjector Sales by Manufacturers
3.1.1 Global Top Sumatriptan Autoinjector Manufacturers by Sales (2017-2022)
3.1.2 Global Sumatriptan Autoinjector Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sumatriptan Autoinjector in 2021
3.2 Global Sumatriptan Autoinjector Revenue by Manufacturers
3.2.1 Global Sumatriptan Autoinjector Revenue by Manufacturers (2017-2022)
3.2.2 Global Sumatriptan Autoinjector Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sumatriptan Autoinjector Revenue in 2021
3.3 Global Sumatriptan Autoinjector Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sumatriptan Autoinjector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sumatriptan Autoinjector Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sumatriptan Autoinjector Sales by Type
4.1.1 Global Sumatriptan Autoinjector Historical Sales by Type (2017-2022)
4.1.2 Global Sumatriptan Autoinjector Forecasted Sales by Type (2023-2028)
4.1.3 Global Sumatriptan Autoinjector Sales Market Share by Type (2017-2028)
4.2 Global Sumatriptan Autoinjector Revenue by Type
4.2.1 Global Sumatriptan Autoinjector Historical Revenue by Type (2017-2022)
4.2.2 Global Sumatriptan Autoinjector Forecasted Revenue by Type (2023-2028)
4.2.3 Global Sumatriptan Autoinjector Revenue Market Share by Type (2017-2028)
4.3 Global Sumatriptan Autoinjector Price by Type
4.3.1 Global Sumatriptan Autoinjector Price by Type (2017-2022)
4.3.2 Global Sumatriptan Autoinjector Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Sumatriptan Autoinjector Sales by Application
5.1.1 Global Sumatriptan Autoinjector Historical Sales by Application (2017-2022)
5.1.2 Global Sumatriptan Autoinjector Forecasted Sales by Application (2023-2028)
5.1.3 Global Sumatriptan Autoinjector Sales Market Share by Application (2017-2028)
5.2 Global Sumatriptan Autoinjector Revenue by Application
5.2.1 Global Sumatriptan Autoinjector Historical Revenue by Application (2017-2022)
5.2.2 Global Sumatriptan Autoinjector Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sumatriptan Autoinjector Revenue Market Share by Application (2017-2028)
5.3 Global Sumatriptan Autoinjector Price by Application
5.3.1 Global Sumatriptan Autoinjector Price by Application (2017-2022)
5.3.2 Global Sumatriptan Autoinjector Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sumatriptan Autoinjector Market Size by Type
6.1.1 North America Sumatriptan Autoinjector Sales by Type (2017-2028)
6.1.2 North America Sumatriptan Autoinjector Revenue by Type (2017-2028)
6.2 North America Sumatriptan Autoinjector Market Size by Application
6.2.1 North America Sumatriptan Autoinjector Sales by Application (2017-2028)
6.2.2 North America Sumatriptan Autoinjector Revenue by Application (2017-2028)
6.3 North America Sumatriptan Autoinjector Market Size by Country
6.3.1 North America Sumatriptan Autoinjector Sales by Country (2017-2028)
6.3.2 North America Sumatriptan Autoinjector Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Sumatriptan Autoinjector Market Size by Type
7.1.1 Europe Sumatriptan Autoinjector Sales by Type (2017-2028)
7.1.2 Europe Sumatriptan Autoinjector Revenue by Type (2017-2028)
7.2 Europe Sumatriptan Autoinjector Market Size by Application
7.2.1 Europe Sumatriptan Autoinjector Sales by Application (2017-2028)
7.2.2 Europe Sumatriptan Autoinjector Revenue by Application (2017-2028)
7.3 Europe Sumatriptan Autoinjector Market Size by Country
7.3.1 Europe Sumatriptan Autoinjector Sales by Country (2017-2028)
7.3.2 Europe Sumatriptan Autoinjector Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sumatriptan Autoinjector Market Size by Type
8.1.1 Asia Pacific Sumatriptan Autoinjector Sales by Type (2017-2028)
8.1.2 Asia Pacific Sumatriptan Autoinjector Revenue by Type (2017-2028)
8.2 Asia Pacific Sumatriptan Autoinjector Market Size by Application
8.2.1 Asia Pacific Sumatriptan Autoinjector Sales by Application (2017-2028)
8.2.2 Asia Pacific Sumatriptan Autoinjector Revenue by Application (2017-2028)
8.3 Asia Pacific Sumatriptan Autoinjector Market Size by Region
8.3.1 Asia Pacific Sumatriptan Autoinjector Sales by Region (2017-2028)
8.3.2 Asia Pacific Sumatriptan Autoinjector Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Sumatriptan Autoinjector Market Size by Type
9.1.1 Latin America Sumatriptan Autoinjector Sales by Type (2017-2028)
9.1.2 Latin America Sumatriptan Autoinjector Revenue by Type (2017-2028)
9.2 Latin America Sumatriptan Autoinjector Market Size by Application
9.2.1 Latin America Sumatriptan Autoinjector Sales by Application (2017-2028)
9.2.2 Latin America Sumatriptan Autoinjector Revenue by Application (2017-2028)
9.3 Latin America Sumatriptan Autoinjector Market Size by Country
9.3.1 Latin America Sumatriptan Autoinjector Sales by Country (2017-2028)
9.3.2 Latin America Sumatriptan Autoinjector Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sumatriptan Autoinjector Market Size by Type
10.1.1 Middle East and Africa Sumatriptan Autoinjector Sales by Type (2017-2028)
10.1.2 Middle East and Africa Sumatriptan Autoinjector Revenue by Type (2017-2028)
10.2 Middle East and Africa Sumatriptan Autoinjector Market Size by Application
10.2.1 Middle East and Africa Sumatriptan Autoinjector Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sumatriptan Autoinjector Revenue by Application (2017-2028)
10.3 Middle East and Africa Sumatriptan Autoinjector Market Size by Country
10.3.1 Middle East and Africa Sumatriptan Autoinjector Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sumatriptan Autoinjector Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Sumatriptan Autoinjector Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Sumatriptan Autoinjector Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Sumatriptan Autoinjector Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Sumatriptan Autoinjector Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Overview
11.3.3 Teva Sumatriptan Autoinjector Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva Sumatriptan Autoinjector Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Sun Pharma
11.4.1 Sun Pharma Corporation Information
11.4.2 Sun Pharma Overview
11.4.3 Sun Pharma Sumatriptan Autoinjector Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharma Sumatriptan Autoinjector Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sumatriptan Autoinjector Industry Chain Analysis
12.2 Sumatriptan Autoinjector Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sumatriptan Autoinjector Production Mode & Process
12.4 Sumatriptan Autoinjector Sales and Marketing
12.4.1 Sumatriptan Autoinjector Sales Channels
12.4.2 Sumatriptan Autoinjector Distributors
12.5 Sumatriptan Autoinjector Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sumatriptan Autoinjector Industry Trends
13.2 Sumatriptan Autoinjector Market Drivers
13.3 Sumatriptan Autoinjector Market Challenges
13.4 Sumatriptan Autoinjector Market Restraints
14 Key Findings in The Global Sumatriptan Autoinjector Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Sumatriptan Autoinjector Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 4mg
Table 3. Major Manufacturers of 6mg
Table 4. Major Manufacturers of Others
Table 5. Global Sumatriptan Autoinjector Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Sumatriptan Autoinjector Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Sumatriptan Autoinjector Sales by Region (2017-2022) & (K Units)
Table 8. Global Sumatriptan Autoinjector Sales Market Share by Region (2017-2022)
Table 9. Global Sumatriptan Autoinjector Sales by Region (2023-2028) & (K Units)
Table 10. Global Sumatriptan Autoinjector Sales Market Share by Region (2023-2028)
Table 11. Global Sumatriptan Autoinjector Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Sumatriptan Autoinjector Revenue Market Share by Region (2017-2022)
Table 13. Global Sumatriptan Autoinjector Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Sumatriptan Autoinjector Revenue Market Share by Region (2023-2028)
Table 15. Global Sumatriptan Autoinjector Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Sumatriptan Autoinjector Sales Share by Manufacturers (2017-2022)
Table 17. Global Sumatriptan Autoinjector Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Sumatriptan Autoinjector Revenue Share by Manufacturers (2017-2022)
Table 19. Sumatriptan Autoinjector Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Sumatriptan Autoinjector Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Sumatriptan Autoinjector by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sumatriptan Autoinjector as of 2021)
Table 22. Sumatriptan Autoinjector Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Sumatriptan Autoinjector Product Offered
Table 24. Date of Manufacturers Enter into Sumatriptan Autoinjector Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sumatriptan Autoinjector Sales by Type (2017-2022) & (K Units)
Table 27. Global Sumatriptan Autoinjector Sales by Type (2023-2028) & (K Units)
Table 28. Global Sumatriptan Autoinjector Sales Share by Type (2017-2022)
Table 29. Global Sumatriptan Autoinjector Sales Share by Type (2023-2028)
Table 30. Global Sumatriptan Autoinjector Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Sumatriptan Autoinjector Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Sumatriptan Autoinjector Revenue Share by Type (2017-2022)
Table 33. Global Sumatriptan Autoinjector Revenue Share by Type (2023-2028)
Table 34. Sumatriptan Autoinjector Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Sumatriptan Autoinjector Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Sumatriptan Autoinjector Sales by Application (2017-2022) & (K Units)
Table 37. Global Sumatriptan Autoinjector Sales by Application (2023-2028) & (K Units)
Table 38. Global Sumatriptan Autoinjector Sales Share by Application (2017-2022)
Table 39. Global Sumatriptan Autoinjector Sales Share by Application (2023-2028)
Table 40. Global Sumatriptan Autoinjector Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Sumatriptan Autoinjector Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Sumatriptan Autoinjector Revenue Share by Application (2017-2022)
Table 43. Global Sumatriptan Autoinjector Revenue Share by Application (2023-2028)
Table 44. Sumatriptan Autoinjector Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Sumatriptan Autoinjector Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Sumatriptan Autoinjector Sales by Type (2017-2022) & (K Units)
Table 47. North America Sumatriptan Autoinjector Sales by Type (2023-2028) & (K Units)
Table 48. North America Sumatriptan Autoinjector Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Sumatriptan Autoinjector Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Sumatriptan Autoinjector Sales by Application (2017-2022) & (K Units)
Table 51. North America Sumatriptan Autoinjector Sales by Application (2023-2028) & (K Units)
Table 52. North America Sumatriptan Autoinjector Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Sumatriptan Autoinjector Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Sumatriptan Autoinjector Sales by Country (2017-2022) & (K Units)
Table 55. North America Sumatriptan Autoinjector Sales by Country (2023-2028) & (K Units)
Table 56. North America Sumatriptan Autoinjector Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Sumatriptan Autoinjector Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Sumatriptan Autoinjector Sales by Type (2017-2022) & (K Units)
Table 59. Europe Sumatriptan Autoinjector Sales by Type (2023-2028) & (K Units)
Table 60. Europe Sumatriptan Autoinjector Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Sumatriptan Autoinjector Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Sumatriptan Autoinjector Sales by Application (2017-2022) & (K Units)
Table 63. Europe Sumatriptan Autoinjector Sales by Application (2023-2028) & (K Units)
Table 64. Europe Sumatriptan Autoinjector Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Sumatriptan Autoinjector Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Sumatriptan Autoinjector Sales by Country (2017-2022) & (K Units)
Table 67. Europe Sumatriptan Autoinjector Sales by Country (2023-2028) & (K Units)
Table 68. Europe Sumatriptan Autoinjector Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Sumatriptan Autoinjector Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Sumatriptan Autoinjector Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Sumatriptan Autoinjector Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Sumatriptan Autoinjector Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Sumatriptan Autoinjector Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Sumatriptan Autoinjector Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Sumatriptan Autoinjector Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Sumatriptan Autoinjector Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Sumatriptan Autoinjector Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Sumatriptan Autoinjector Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Sumatriptan Autoinjector Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Sumatriptan Autoinjector Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Sumatriptan Autoinjector Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Sumatriptan Autoinjector Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Sumatriptan Autoinjector Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Sumatriptan Autoinjector Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Sumatriptan Autoinjector Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Sumatriptan Autoinjector Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Sumatriptan Autoinjector Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Sumatriptan Autoinjector Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Sumatriptan Autoinjector Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Sumatriptan Autoinjector Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Sumatriptan Autoinjector Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Sumatriptan Autoinjector Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Sumatriptan Autoinjector Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Sumatriptan Autoinjector Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Sumatriptan Autoinjector Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Sumatriptan Autoinjector Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Sumatriptan Autoinjector Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Sumatriptan Autoinjector Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Sumatriptan Autoinjector Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Sumatriptan Autoinjector Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Sumatriptan Autoinjector Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Sumatriptan Autoinjector Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Sumatriptan Autoinjector Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Sumatriptan Autoinjector Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Sumatriptan Autoinjector Revenue by Country (2023-2028) & (US$ Million)
Table 106. GlaxoSmithKline Corporation Information
Table 107. GlaxoSmithKline Description and Major Businesses
Table 108. GlaxoSmithKline Sumatriptan Autoinjector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. GlaxoSmithKline Sumatriptan Autoinjector Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. GlaxoSmithKline Recent Developments
Table 111. Pfizer Corporation Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Sumatriptan Autoinjector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Pfizer Sumatriptan Autoinjector Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Teva Corporation Information
Table 117. Teva Description and Major Businesses
Table 118. Teva Sumatriptan Autoinjector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Teva Sumatriptan Autoinjector Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Teva Recent Developments
Table 121. Sun Pharma Corporation Information
Table 122. Sun Pharma Description and Major Businesses
Table 123. Sun Pharma Sumatriptan Autoinjector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Sun Pharma Sumatriptan Autoinjector Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Sun Pharma Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Sumatriptan Autoinjector Distributors List
Table 129. Sumatriptan Autoinjector Customers List
Table 130. Sumatriptan Autoinjector Market Trends
Table 131. Sumatriptan Autoinjector Market Drivers
Table 132. Sumatriptan Autoinjector Market Challenges
Table 133. Sumatriptan Autoinjector Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Sumatriptan Autoinjector Product Picture
Figure 3. Global Sumatriptan Autoinjector Market Share by Type in 2021 & 2028
Figure 3. 4mg Product Picture
Figure 4. 6mg Product Picture
Figure 5. Others Product Picture
Figure 6. Global Sumatriptan Autoinjector Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Sumatriptan Autoinjector Report Years Considered
Figure 11. Global Sumatriptan Autoinjector Sales 2017-2028 (K Units)
Figure 12. Global Sumatriptan Autoinjector Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Sumatriptan Autoinjector Revenue 2017-2028 (US$ Million)
Figure 14. Global Sumatriptan Autoinjector Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Sumatriptan Autoinjector Sales Market Share by Region (2017-2022)
Figure 16. Global Sumatriptan Autoinjector Sales Market Share by Region (2023-2028)
Figure 17. North America Sumatriptan Autoinjector Sales YoY (2017-2028) & (K Units)
Figure 18. North America Sumatriptan Autoinjector Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Sumatriptan Autoinjector Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Sumatriptan Autoinjector Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Sumatriptan Autoinjector Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Sumatriptan Autoinjector Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Sumatriptan Autoinjector Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Sumatriptan Autoinjector Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Sumatriptan Autoinjector Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Sumatriptan Autoinjector Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Sumatriptan Autoinjector Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Sumatriptan Autoinjector in the World: Market Share by Sumatriptan Autoinjector Revenue in 2021
Figure 29. Global Sumatriptan Autoinjector Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Sumatriptan Autoinjector Sales Market Share by Type (2017-2028)
Figure 31. Global Sumatriptan Autoinjector Revenue Market Share by Type (2017-2028)
Figure 32. Global Sumatriptan Autoinjector Sales Market Share by Application (2017-2028)
Figure 33. Global Sumatriptan Autoinjector Revenue Market Share by Application (2017-2028)
Figure 34. North America Sumatriptan Autoinjector Sales Market Share by Type (2017-2028)
Figure 35. North America Sumatriptan Autoinjector Revenue Market Share by Type (2017-2028)
Figure 36. North America Sumatriptan Autoinjector Sales Market Share by Application (2017-2028)
Figure 37. North America Sumatriptan Autoinjector Revenue Market Share by Application (2017-2028)
Figure 38. North America Sumatriptan Autoinjector Sales Share by Country (2017-2028)
Figure 39. North America Sumatriptan Autoinjector Revenue Share by Country (2017-2028)
Figure 40. U.S. Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Sumatriptan Autoinjector Sales Market Share by Type (2017-2028)
Figure 43. Europe Sumatriptan Autoinjector Revenue Market Share by Type (2017-2028)
Figure 44. Europe Sumatriptan Autoinjector Sales Market Share by Application (2017-2028)
Figure 45. Europe Sumatriptan Autoinjector Revenue Market Share by Application (2017-2028)
Figure 46. Europe Sumatriptan Autoinjector Sales Share by Country (2017-2028)
Figure 47. Europe Sumatriptan Autoinjector Revenue Share by Country (2017-2028)
Figure 48. Germany Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 49. France Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Sumatriptan Autoinjector Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Sumatriptan Autoinjector Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Sumatriptan Autoinjector Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Sumatriptan Autoinjector Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Sumatriptan Autoinjector Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Sumatriptan Autoinjector Revenue Share by Region (2017-2028)
Figure 59. China Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 62. India Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Sumatriptan Autoinjector Sales Market Share by Type (2017-2028)
Figure 70. Latin America Sumatriptan Autoinjector Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Sumatriptan Autoinjector Sales Market Share by Application (2017-2028)
Figure 72. Latin America Sumatriptan Autoinjector Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Sumatriptan Autoinjector Sales Share by Country (2017-2028)
Figure 74. Latin America Sumatriptan Autoinjector Revenue Share by Country (2017-2028)
Figure 75. Mexico Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Sumatriptan Autoinjector Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Sumatriptan Autoinjector Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Sumatriptan Autoinjector Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Sumatriptan Autoinjector Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Sumatriptan Autoinjector Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Sumatriptan Autoinjector Revenue Share by Country (2017-2028)
Figure 84. Turkey Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Sumatriptan Autoinjector Revenue (2017-2028) & (US$ Million)
Figure 87. Sumatriptan Autoinjector Value Chain
Figure 88. Sumatriptan Autoinjector Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

---